Last Updated: November 8, 2026

Details for New Drug Application (NDA): 070101

« Back to Dashboard

NDA 070101 describes DISOPYRAMIDE PHOSPHATE, which is a drug marketed by Nesher Pharms, Dr Reddys Labs Sa, Interpharm, Ivax Sub Teva Pharms, Mylan, Rising, Sun Pharm Industries, Superpharm, Teva, and Watson Labs, and is included in eighteen NDAs. It is available from two suppliers. Additional details are available on the DISOPYRAMIDE PHOSPHATE profile page.

The generic ingredient in DISOPYRAMIDE PHOSPHATE is disopyramide phosphate. There is one drug master file entry for this compound. Four suppliers are listed for this compound. Additional details are available on the disopyramide phosphate profile page.

Summary for 070101

Tradename:	DISOPYRAMIDE PHOSPHATE
Applicant:	Teva
Ingredient:	disopyramide phosphate
Patents:	0

Pharmacology for NDA: 070101

Medical Subject Heading (MeSH) Categories for 070101

Anti-Arrhythmia Agents
Voltage-Gated Sodium Channel Blockers

Suppliers and Packaging for NDA: 070101

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
DISOPYRAMIDE PHOSPHATE	disopyramide phosphate	CAPSULE;ORAL	070101	ANDA	Teva Pharmaceuticals USA, Inc.	0093-3127	0093-3127-01	100 CAPSULE in 1 BOTTLE (0093-3127-01)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	CAPSULE;ORAL			Strength	EQ 100MG BASE
Approval Date:	Feb 22, 1985	TE:	AB	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.